Summary & Overview
HCPCS S0078: Injection, Fosphenytoin Sodium 750 mg
HCPCS Level II code S0078 denotes a single-dose injection of fosphenytoin sodium, 750 mg, an intravenous or intramuscular anticonvulsant used for acute seizure control. The code matters nationally because fosphenytoin is a commonly used parenteral antiepileptic in emergency and inpatient care; accurate coding affects clinical documentation, hospital billing, and medication utilization tracking across payers.
Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find an overview of coverage considerations and payer policies, typical sites of service where the code is billed, and clinical context for use in acute seizure management. The publication provides benchmarks for utilization where available, summarizes relevant policy updates that affect coding and reimbursement workflows, and outlines implications for revenue cycle and compliance teams.
This summary is intended for national audiences including hospital billing staff, clinicians involved in acute seizure care, revenue cycle managers, and policy analysts seeking a concise reference for S0078 in the context of parenteral anticonvulsant administration.
Billing Code Overview
HCPCS Level II code S0078 represents Injection, fosphenytoin sodium, 750 mg. This service is an intravenous or intramuscular anticonvulsant medication administration used for acute management of seizures and seizure prevention in clinical settings. The service type is medication injection/administration.
The typical site of service for S0078 is emergent and inpatient settings, including emergency departments, hospital inpatient units, and observation units where parenteral anticonvulsant therapy is administered.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to the emergency department or inpatient unit with generalized tonic-clonic seizures or status epilepticus that are refractory to initial benzodiazepine therapy. The treating team elects to administer an anticonvulsant parenteral agent; S0078 describes a 750 mg dose of injectable fosphenytoin sodium used for rapid loading or conversion from phenytoin when intravenous access is required. The clinical workflow includes seizure assessment, airway and hemodynamic stabilization, establishment of IV access, review of medication allergies and cardiac history (QT interval, conduction disease), calculation of weight-based dosing, preparation and administration of the injection (often via slow IV push or short infusion per institutional protocol), cardiac monitoring during and after administration, and documentation of dose, route, lot number, and patient response. Typical sites of service are the emergency department, inpatient ward, intensive care unit, and occasionally the operating room for perioperative seizure prophylaxis. Nursing documents medication administration and monitoring; the prescribing physician documents indication, dose, and response. Billing uses S0078 for the 750 mg fosphenytoin sodium injection, with applicable modifiers to reflect circumstances such as anesthesia involvement, discontinued service, or drug wastage.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 |